Prescription drug · NDA AUTHORIZED GENERIC
Tafluprost Ophthalmic (Tafluprost) NDC 66993-429
Tafluprost .0045 mg/.3mL · Solution/ drops · Ophthalmic · Prasco Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66993-429-30 | 6699304293066993042930 | 3 POUCH in 1 CARTON (66993-429-30) / 10 VIAL, SINGLE-USE in 1 POUCH (66993-429-81) / .3 mL in 1 VIAL, SINGLE-USEMarketed from Nov 18, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tafluprost Ophthalmic
- Generic name (nonproprietary)
- tafluprost
- Active ingredients
- Tafluprost — .0045 mg/.3mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Prasco LaboratoriesNDC labeler code 66993
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 202514
- Marketing start
- Listing expires
- Other FDA classes
- Increased Prostaglandin Activity (Physiologic effect)Prostaglandin Receptor Agonists (Mechanism)Prostaglandins (Chemical structure)
- Identifiers
- Product ID 66993-429_c8695339-0d5e-4988-b411-f094676b77bfSPL ID c8695339-0d5e-4988-b411-f094676b77bfSPL set ID 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368RxCUI 1244611UNII 1O6WQ6T7G3UPC 0366993429816
- Pharmacologic class
- Prostaglandin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466993042930followed by a unit qualifier and the quantityPackage 66993-0429-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tafluprost Ophthalmic Solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Tafluprost Ophthalmic Solution 0.0015% is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 66993-429
- What is NDC 66993-429?
- 66993-429 is the product NDC for Tafluprost Ophthalmic (tafluprost), Tafluprost .0045 mg/.3mL solution/ drops, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tafluprost Ophthalmic (Tafluprost).
- What is the active ingredient?
- Tafluprost.
- Who is the labeler?
- Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tafluprost Ophthalmic?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 202514
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zioptantafluprost | Tafluprost .015 mg/mL | Solution/ dropsOphthalmic | Thea Pharma Inc. | 82584-609 |